Oceania Healthcare Limited Ordinary Shares
OCA.NZXHealth Care
Oceania operates in the New Zealand residential aged care and retirement village sectors, offering residents villas and apartments within its retirement villages, and also providing a full range of residential aged care services (including rest home, hospital and dementia level care) at its aged care facilities. Oceania is currently New Zealand's third largest provider of residential aged care, and New Zealand's sixth largest retirement village business. Oceania is the freehold owner of 47 of its 50 nationwide sites, comprising 48 aged care and retirement village facilities and two sites held for redevelopment purposes. Oceania is also an experienced brownfields developer of aged care and retirement village facilities throughout New Zealand. Oceania Healthcare Limited first listed on the New Zealand and Australian Stock Exchanges on 5 May 2017 under the code "OCA".
Market Data
$0.775
+0.0%$561.3M
3875.0x
$0.000
0.00%
+0.3%
Latest Earnings
FY26 Results Supplementary Information
25 May 2026
Retirement village operator reported embedded value growth of 2% to NZ$600.1m as at FY26, comprising NZ$326.2m of accrued deferred management fees (DMF) and NZ$274.0m of resale gains. Growth was driven by sell-down of stock, changes in ORA terms at The Helier, and onboarding of new developments at Franklin and Meadowbank. Available stock levels declined materially year-on-year, with total new units falling from 337 to 258 and total resale units falling from 190 to 167, suggesting improved inventory absorption. Key points: Embedded value increased 2% to NZ$600.1m (FY25: NZ$591.0m) as independently valued by CBRE Limited at 31 March 2026; Accrued DMF component of NZ$326.2m represents a meaningful increase from FY25's NZ$293m, reflecting portfolio maturation; Unsold stock reduced by 33% from NZ$392.2m to NZ$264.0m, indicating strong sell-down progress
Recent Announcements
FY26 Results Supplementary Information
Retirement village operator reported embedded value growth of 2% to NZ$600.1m as at FY26, comprising NZ$326.2m of accrued deferred management fees (DMF) and NZ$274.0m of resale gains. Growth was driven by sell-down of stock, changes in ORA terms at The Helier, and onboarding of new developments at Franklin and Meadowbank. Available stock levels declined materially year-on-year, with total new units falling from 337 to 258 and total resale units falling from 190 to 167, suggesting improved inventory absorption. Key points: Embedded value increased 2% to NZ$600.1m (FY25: NZ$591.0m) as independently valued by CBRE Limited at 31 March 2026; Accrued DMF component of NZ$326.2m represents a meaningful increase from FY25's NZ$293m, reflecting portfolio maturation; Unsold stock reduced by 33% from NZ$392.2m to NZ$264.0m, indicating strong sell-down progress
OCA delivered record full year result
Oceania Healthcare (OCA) delivered a record FY26 result for the year ended 31 March 2026, with Proforma Underlying EBITDA growing 20% to $97.7m and total sales volumes up 16% to 603 units despite subdued residential property market conditions. Proforma Underlying NPAT rose 34% to $64.1m, while net debt reduced by $121.4m to $506.7m, bringing gearing to 30.1% at the lower end of the 30-35% target range. No dividend was declared for FY26, with the Board targeting a return to positive Free Cash Flow from Operations in FY27 before resuming payments. Key points: Record Proforma Underlying EBITDA of $97.7m, up 20% on FY25, and Proforma Underlying NPAT of $64.1m, up 34% on FY25; Record total sales volumes of 603 units, up 16% on FY25, with gross value of settled sales up 20% to $375m; Net debt reduced by $121.4m to $506.7m, with gearing falling to 30.1% at the lower end of the 30-35% target range and facility headroom exceeding $200m
Full Year Results - 22 May 2026
Upcoming full year results expected 22 May 2026 (from NZX schedule)
Notice of Full Year Result Announcement
Oceania Healthcare Limited has announced it will release its full year results for the twelve months ending 31 March 2026 on 22 May 2026. This notice contains no financial data, only scheduling details for the results announcement and webcast hosted by the CEO and CFO. No financial metrics or guidance have been provided at this time. Key points: Full year results for FY2026 (12 months to 31 March 2026) scheduled for release on 22 May 2026; Results will be lodged with both NZX and ASX simultaneously; Investor webcast scheduled for 11:00am NZST / 9:00am AEST on 22 May 2026, hosted by CEO Suzanne Dvorak and CFO Kathryn Waugh
Update on divestments
Oceania Healthcare Limited (NZX/ASX: OCA) announced it will complete six divestments totalling approximately $50 million by 31 March 2026, exceeding its prior target of four divestments for $40 million. The company will use proceeds to reduce net debt, with all sites sold at carrying value and divested assets including six villages comprising 299 care beds, 46 independent living units, and 14 care suites.
SPH Notice - ANZ New Zealand Investments Limited
ANZ New Zealand Investments Limited changed substantial holding from 9.783% to 6.642%.
SPH Notice - Forsyth Barr Investment Management Limited
Forsyth Barr Investment Management Limited changed substantial holding from 11.238% to 12.240%.
Oceania announces Director changes as part of Board refresh
Oceania Healthcare Limited (NZX/ASX: OCA) appointed Ms Sarah Ottrey as an independent non-executive director effective 5 February 2026, while director Sally Evans announced her intention to retire at the next Annual Shareholder Meeting. The changes are part of the Board's planned refresh and ongoing succession strategy.
Annual Report
Oceania Healthcare delivered a solid FY25 result for the year ended 31 March 2025, with underlying EBITDA rising 4.1% to $86.0m and operating cash flow up 6.7% to $110.3m, driven by a 9.2% increase in sales volumes and improved care occupancy of 94.5%. Total Comprehensive Income grew 5.8% to $74.6m, though statutory NPAT declined 3.5% to $30.4m. The company divested six non-core sites, refinanced its banking facilities, and is targeting $10–15m in annualised cost savings, while the Board resolved not to declare a final dividend pending a policy review. Key points: Underlying EBITDA rose 4.1% to $86.0m and operating cash flow increased 6.7% to $110.3m, reflecting improved sales momentum and care earnings.; Total sales volumes up 9.2% on pcp, with new sale volumes increasing 17.2% to 184 ILUs and care suites, and resales up 5.3%.; Care occupancy improved to 94.5% (excluding development sites), up from 92.6% in pcp.
Notice of Result Announcement
Oceania Healthcare Limited has issued a notice that it will announce its full year results for the year ended 31 March 2025 on 22 May 2025. This is a preliminary notice only and contains no financial results or metrics. A webcast will be hosted by the CEO and CFO at 11am NZST on the same day. Key points: Full year results for the year ended 31 March 2025 will be released on 22 May 2025; Results webcast will be hosted by CEO Suzanne Dvorak and CFO Kathryn Waugh at 11am NZST / 9am AEST; Results will be lodged with both NZX and ASX simultaneously
Get real-time alerts for OCA
Receive AI-powered earnings summaries and instant notifications when Oceania Healthcare Limited Ordinary Shares releases results.
Register Free